Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women.

نویسندگان

  • Miriam J J de Kleijn
  • Yvonne T van der Schouw
  • André L M Verbeek
  • Petra H M Peeters
  • Jan-Dirk Banga
  • Yolanda van der Graaf
چکیده

In this study, the authors investigated whether combined information on reproductive factors has additive value to the single reproductive factor age at menopause for assessing endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women. They conducted a population-based cohort study that included 9,450 postmenopausal women from Nijmegen, the Netherlands, who were aged 35--65 years at enrollment in 1975, with a median follow-up of 20.5 years. A Cox proportional hazards model and Receiver Operating Curves were used to analyze the data. Women aged 52 years or more at menopause had an 18% reduction in cardiovascular mortality (hazard ratio = 0.82, 95% confidence interval (CI): 0.69, 0.98) compared with those aged 44 years or less. Women with more than 18 years of exposure to endogenous estrogen had a statistically significant 20% reduction in cardiovascular mortality (hazard ratio = 0.80, 95 percent CI: 0.67, 0.96) compared with those who had 13 years of exposure or less. The area under the curve of the Receiver Operating Curves for the two models was identical (area under the curve = 0.67, 95 percent CI: 0.66, 0.68). This study shows that age at menopause is related to cardiovascular disease mortality and that a newly developed composite measure of endogenous estrogen exposure does not add to the predictive value of age at menopause for cardiovascular mortality.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

اثرات استروژن درمانی در زنان یائسه و ارتباط آن با سرطان پستان

Low levels of endogenous estrogens in postmenopausal women lead to several clinical problems. Some of these problems can be resolved by estrogen replacement therapy. The role of estrogen therapy in increasing the risk of breast cancer has not been well known yet. So, it was decided to study this controversial issue. In this study, 122 postmenopausal women, ranging in age from 46 to 61 years, we...

متن کامل

Comparison of the effect of combined physical training (endurance, strength) with and without flaxseed on the levels of estrogen, lipid and body composition of inactive menopausal women

Background & Aim: Increase in cardiovascular disease risk factors in postmenopausal women is because of adverse changes in plasma lipoproteins due to the lack of estrogen. The aim of this study was to investigate the effect of eight weeks of combined training with and without flaxseed consumption on estrogen, lipid level and body composition in sedentary postmenopausal ‎women. Methods: In this...

متن کامل

طراحی تاثیر تمرینات هوازی بر سطح پلاسمایی اکسید نیتریک و عملکرد اندوتلیوم عروق زنان یائسه

 Background: Cardiovascular disease is one of the main causes of morbidity and mortality in postmenopausal women. Physiological decrease in estrogen levels and accumulation of visceral fat and being overweight, increase the risk of cardiovascular disorders in the menopausal years. The aim of this study was to determine the effects of aerobic exercising on plasma nitric oxide level and ...

متن کامل

Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review

Coronary heart disease is the main cause of death in postmenopausal women (PMW); moreover its mortality exceeds those for breast cancer in women at all ages. Type II diabetes mellitus is a major cardiovascular risk factor and there is some evidence that the risk conferred by diabetes is greater in women than in men. It was established that the deficiency of endogenous estrogens promotes the ath...

متن کامل

Hormone therapy and asymmetrical dimethylarginine in postmenopausal women.

Women present an estradiol-dependent cardiovascular risk profile. Based on various studies, it was considered that estrogen therapy (ET) in postmenopausal women could probably reduce the higher cardiovascular risk in this group. Assymetric dimethylarginine (ADMA) is an endogenous methylated arginine which inhibits nitric oxide (NO) synthesis by competing with the substrate of NO, L-arginine, le...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • American journal of epidemiology

دوره 155 4  شماره 

صفحات  -

تاریخ انتشار 2002